GE HealthCare supplies medical imaging, ultrasound, patient monitoring and pharmaceutical diagnostics used in hospitals and clinics worldwide. Spun out of General Electric, it focuses on equipment and software that support diagnosis, guided procedures and clinical workflows rather than drugs or hospital ownership. Customers are health systems and providers seeking capital equipment and associated services for radiology, cardiology and critical care.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 5,006 | — | 486 | 6.5% |
| Q3 2025 | 5,144 | — | 446 | -14.8% |
| Q4 2025 | 5,698 | — | 589 | -11.1% |
| Q1 2026 | 5,131 | — | 389 | -15.8% |
| Q2 2026 | 5,294 | 5.8% | 561 | 15.4% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Cognizant Technology Solutions Corporation (CTSH), United Airlines Holdings, Inc. (UAL), Alnylam Pharmaceuticals, Inc. (ALNY), Huntington Bancshares Incorporated (HBAN), Northern Trust Corporation (NTRS), Cerebras Systems Inc. (CBRS)